Tudor Investment Corp Et Al Makes New $169,000 Investment in Metacrine, Inc. (NASDAQ:MTCR)
Tudor Investment Corp Et Al bought a new stake in Metacrine, Inc. (NASDAQ:MTCR – Get Rating) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissi
Defense WorldMar 11, 2023 05:51 ET
Nasdaq to Delist Shares of Waitr and Calithera Biosciences, Among Others
Seeking AlphaMar 1, 2023 18:26 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersHTG Molecular Diagnostics (NASDAQ:HTGM) shares moved upwards by 33.0% to $6.01 during Wednesday's after-market session. This security traded at a volume of 323.6K shares come close, making up 2
Benzinga Real-time NewsFeb 1, 2023 16:32 ET
Insider Selling: Metacrine, Inc. (NASDAQ:MTCR) CEO Sells $156,048.05 in Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) CEO Preston Klassen sold 380,605 shares of the company's stock in a transaction that occurred on Thursday, January 26th. The stock was sold at an average pr
Financial News LiveJan 30, 2023 04:51 ET
Preston Klassen Sells 380,605 Shares of Metacrine, Inc. (NASDAQ:MTCR) Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) CEO Preston Klassen sold 380,605 shares of the firm's stock in a transaction on Thursday, January 26th. The stock was sold at an average price of $0.41, for
Defense WorldJan 29, 2023 05:51 ET
Insider Selling: Metacrine, Inc. (NASDAQ:MTCR) Insider Sells 107,054 Shares of Stock
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) insider Michael York sold 107,054 shares of Metacrine stock in a transaction on Thursday, January 26th. The stock was sold at an average price of $0.41, for
kopsourceJan 27, 2023 18:35 ET
Insider Sell: Metacrine
04:46 PM EST, 01/27/2023 (MT Newswires) -- Preston Klassen, Director, President and CEO, on January 26, 2023, sold 380,605 shares in Metacrine (MTCR) for $157,266. Following the Form 4 filing with the
MT NewswiresJan 27, 2023 16:48 ET
Metacrine, Inc. (NASDAQ:MTCR) Sees Significant Decrease in Short Interest
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 87,400 shares, a decrease
Financial News LiveJan 26, 2023 20:44 ET
Metacrine (NASDAQ:MTCR) Shares Up 9.5%
Metacrine, Inc. (NASDAQ:MTCR – Get Rating)'s share price shot up 9.5% on Wednesday . The company traded as high as $0.50 and last traded at $0.48. 1,115,206 shares were traded during trading, an inc
Defense WorldJan 26, 2023 02:01 ET
Metacrine Says President, CEO, Secretary, Principal Executive Officer Preston Klassen Was Terminated From Positions, Effective Feb. 1
Metacrine Says President, CEO, Secretary, Principal Executive Officer Preston Klassen Was Terminated From Positions, Effective Feb. 1
Benzinga Real-time NewsJan 24, 2023 17:22 ET
SHAREHOLDER ALERT: Weiss Law Reminds MTCR, OFIX, APEN, and TCFC Shareholders About Its Ongoing Investigations
NEW YORK, Dec. 30, 2022 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your righ
PR NewswireDec 30, 2022 08:40 ET
Metacrine, Equillium And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:Metacrine, Inc. (NASDAQ:MTCR) and Equillium, Inc. (NASDAQ:EQ) mutuall
Benzinga Real-time NewsDec 27, 2022 04:12 ET
Equillium, Metacrine Agree to Terminate Proposed Merger
03:48 AM EST, 12/27/2022 (MT Newswires) -- Equillium (EQ) and Metacrine (MTCR) said late Friday they have mutually agreed to terminate their proposed merger. Equillium aimed to purchase Metacrine in a
MT NewswiresDec 27, 2022 03:49 ET
Metacrine Shares Rise 10% Following Scrapped Equillium Deal
By Denny Jacob Metacrine Inc. shares rose 10% to 48 cents in after-hours trading Friday after the company and Equillium Inc. mutually agreed to terminate their merger deal. The biotechnology company
Dow JonesDec 23, 2022 16:57 ET
Metacrine Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 14%
Metacrine Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 14%
Benzinga Real-time NewsDec 23, 2022 16:31 ET
Equillium, Metacrine Agree to Terminate Merger Deal
By Sabela Ojea Equillium Inc. said Friday that it terminated its merger deal with biotechnology company Metacrine Inc. by mutual agreement. The clinical-stage biotechnology company said it first app
Dow JonesDec 23, 2022 16:30 ET
Metacrine, Equillium Call off Merger
Seeking AlphaDec 23, 2022 16:22 ET
Metacrine Common Stock Shares To Resume Trade At 4:30 P.m. ET
Metacrine Common Stock Shares To Resume Trade At 4:30 p.m. ET
Benzinga Real-time NewsDec 23, 2022 16:14 ET
Metacrine Shares Halted, News Pending
Metacrine Shares Halted, News Pending
Benzinga Real-time NewsDec 23, 2022 16:02 ET
Express News | Metacrine and Equillium Agree to Terminate Merger Agreement >MTCR
Moomoo 24/7Dec 23, 2022 16:02 ET
No Data
No Data